Quality Care
The collaboration combines the companies' menopause and virtual care offerings to broaden access to care services for women navigating symptoms of menopause.
The alliance aims to support early-stage entrepreneurs developing AI applications in healthtech, medtech and biotech.
The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine will utilize CancerIQ’s AI platform for personalized risk assessments and advanced early detection.
The company's FDA-cleared autonomous ultrasound imaging system uses a probe to allow for imaging in resource-limited environments to support trauma medicine.
A first deployment at Sumedang regency will focus on addressing tuberculosis, stunting, and hypertension.
Also, MediBuddy in India has developed an AI to detect fraudulent claims.
The company will use the funds to expand the adoption of its surgical software and fund mergers and acquisitions.
Peak body RACGP has recently released its guidance for adopting the technology.
It is also solidifying its presence in the United States market through Cedars-Sinai's backing.
The company's purchase will allow it to expand into the U.K. market.